In 2003, the FDA approved generic gabapentin, and it's now made by several drug companies. An extended-release form of gabapentin is available under the brand name Horizant. In 2004, the drug maker Pfizer settled charges for marketing Neurontin for unapproved uses, and agreed to pay $430 million.